Evolving criteria for post-operative biochemical remission of acromegaly: Can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature

Endocrine-Related Cancer

Volumn 10, Issue 4, 2003, Pages 611-619

  Minniti, G ^a   Jaffrain Rea, M L ^b,c   Esposito, V ^a,d   Santoro, A ^d   Tamburrano, G ^e   Cantore, G ^a,d  

^a IRCCS NEUROMED   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c Fondazione 'Carlo Ferri'   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CAVERNOUS SINUS; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL AUDIT; MEDICAL LITERATURE; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PREDICTION; PROSPECTIVE STUDY; QUALITY OF LIFE; REVIEW; SPHENOID; SURGICAL APPROACH; TREATMENT OUTCOME;

ACROMEGALY; ADENOMA; ADULT; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PITUITARY NEOPLASMS; POSTOPERATIVE PERIOD; PROGNOSIS; PROLACTIN; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 0347087567     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0100611     Document Type: Review

References (48)

1. Abe T & Ludecke DK 2001 Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. European Journal of Endocrinology 145 137-145.
2. Abosch A, Tyrrel JB, Lamborn KR, Hannegan LT, Applebury CB & Wilson CB 1998 Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. Journal of Clinical Endocrinology and Metabolism 83 3411-3418.
3. Ahmed S, Elsheikh M, Stratton IM, Page RCL, Adams CBT & Wass JAH 1999 Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clinical Endocrinology 50 561-567.
4. Arafah BM, Rosenzweig JL, Fenstermaker R, Salazar R, McBride CE & Selman W 1987 Value of growth hormone dynamics and somatomedin C (insulin-like growth factor 1) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly. Journal of Laboratory and Clinical Medicine 109 346-354.
5. Arafah BM, Kailani SH, Nekl KE, Gold RS & Selman WR 1994 Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. Journal of Clinical Endocrinology and Metabolism 79 348-354.
6. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP & Bertherat J 2000 Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. Journal of Clinical Endocrinology and Metabolism 85 3779-3785.
7. Bates A, Van't Hoff W, Jones J & Clayton R 1993 An audit of the outcome of acromegaly. Quarterly Journal of Medicine 86 293-299.
8. Bates AS, Van't Hoff W, Jones JM & Clayton RN 1995 Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion. Clinical Endocrinology 42 417-423.
9. Beauregard C, Truong U, Hardy J & Serri O 2003 Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology 58 86-91.
10. Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA, McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA & Wardlaw JM 2002 Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size. Journal of Clinical Endocrinology and Metabolism 87 4554-4563.
11. Buchfelder M, Brockmeier S, Fahlbusch R, Honegger J, Pichl J & Manzl M 1991 Recurrence following transsphenoidal surgery for acromegaly. Hormone Research 35 113-118.
12. Colao A, Merola B, Ferone D & Lombardi G. 1997a Acromegaly. Journal of Clinical Endocrinology and Metabolism 8 2777-2781.
13. Colao A, Ferone D, Cappabianca P, del Basso, De Caro ML, Marzullo P, Monticelli A, Alfieri A, Merola B, Cali A, de Divitiis E & Lombardi G 1997b Effect of octreotide pretreatment on surgical outcome in acromegaly. Journal of Clinical Endocrinology and Metabolism 82 3308-3314.
14. Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte AM, Pivonello R, Salvatore M & Lombardi G 2001 Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalisation of growth hormone and insulin-like growth factor I levels on cardiac performance. Journal of Clinical Endocrinology and Metabolism 86 1551-1557.
15. Davis DH, Laws ER Jr, Ilstrup DM, Speed JK, Caruso M, Shaw EG, Abboud CF, Scheithauer BW, Root LM & Schleck C 1993 Results of surgical treatment for growth hormone-secreting pituitary adenomas. Journal of Neurosurgery 79 70-75.
16. Dimaraky EV, Jaffe CA, DeMott-Friberg R, Chandler WF & Barkan AL 2002 Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. Journal of Clinical Endocrinology and Metabolism 87 3537-3542.
17. Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernandez I, Ovalle A & Mendoza V 2002 Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly. Journal of Neurosurgery 97 287-292.
18. Fahlbusch R, Honegger J & Buchfelder M 1992 Surgical management of acromegaly. Endocrinology and Metabolism Clinics of North America 21 669-692.
19. Freda PU 2002 Somatostatin analogs in acromegaly. Journal of Clinical Endocrinology and Metabolism 87 3013-3018.
20. Freda PU, Wardlaw SL & Post KD 1998 Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. Journal of Neurosurgery 89 353-358.
21. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K & Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism 85 526-529.
22. Jaffrain-Rea ML, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A, Infusino T, Tamburrano G, Cantore G & Cassone R 2003 Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. European Journal of Endocrinology 148 193-120.
23. Kreutzer J, Vance ML, Lopes MBS & Laws ER 2001 Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. Journal of Clinical Endocrinology and Metabolism 86 4072-4077.
24. Kristof RA, Stoffel-Wagner B, Klingmuller D & Schramm J 1999 Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study. Acta Neurochirurgica 141 399-405.
25. Kristof RA, Neuloh G, Redel L, Klingmuller D & Schramm J 2002 Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission. Journal of Neurosurgery 97 1282-1286.
26. Lamberts SW, Reubi JC & Krenning EP 1992 Somatostatin analogs in the treatment of acromegaly. Endocrinology and Metabolism Clinics of North America 21 737-752.
27. Laws ER, Vance ML & Thapar K 2000 Pituitary surgery for the management of acromegaly. Hormone Research 53 71-75.
28. Lissett CA, Peacey SR, Laing I, Tetlow L, David JRE & Shalet SM 1998 The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenomas. Clinical Endocrinology 49 658-667.
29. Losa M, Oeckler R, Schopohl J, Muller O, Alba-Lopez J & von Werder K 1989 Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. Journal of Neurosurgery 70 561-567.
30. Losa M, Mortini P & Giovanelli M 1999 Is presurgical treatment with somatostatin analogs necessary in acromegalic patients? Journal of Clinical Investigation 22 871-873.
31. Melmed S 1990 Acromegaly. The New England Journal of Medicine 322 966-977.
32. Melmed S, Ho K, Klibanski A, Reichlin S & Thomer M 1995 Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly. Journal of Clinical Endocrinology and Metabolism 80 3395-3402.
33. Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleimberg D, Lamberts S, Laws E, Lombardi G, Vance ML, Werder KW, Wass J & Giustina A 2002 Guidelines for acromegaly management. Journal of Clinical Endocrinology and Metabolism 87 4054-4058.
34. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Moroni C, Lenzi J, Tamburrano G, Cassone R & Cantore G 2001a Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients. Acta Neurochirurgica 143 1205-1211.
35. Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C, Cantore G, Tamburrano G & Cassone R 2001b Marked improvement of cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clinical Endocrinology 55 307-313.
36. Peacey S & Shalet SM 2001 Insulin-like growth factor measurement in diagnosis and management of acromegaly. Annals of Clinical Biochemistry 38 297-303.
37. Powell JS, Wardlaw SL, Post KD & Freda PU 2000 Outcome of radiotherapy for acromegaly using normalisation of insulin-like growth factor to define cure. Journal of Clinical Endocrinology and Metabolism 85 2068-2071.
38. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ & Ibbertson HK 1994 Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology 41 95-102.
39. Ross DA & Wilson CB 1988 Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas in a series of 214 patients. Journal of Neurosurgery 68 854-867.
40. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM & Wass JA 1996 Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clinical Endocrinology 45 407-413.
41. Shimon I, Cohen ZR, Ram Z & Hadani M 2001 Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48 1239-1243.
42. Stoffel-Wagner B, Springer W, Bidlingmaier F & Klingmueller D 1997 Investigation of the criteria for assessing the outcome of treatment in acromegaly. Clinical Endocrinology 46 531-537.
43. Swearingen B, Barker FG II, Katznelson L, Biller BMK, Grinspoon S, Klibanski A, Moayeri N, Black PM & Zervas NT 1998 Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism 83 3419-3426.
44. Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH & Adams DA 1993 Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. Journal of Neurosurgery 78 205-215.
45. Valdemarsson S, Bramnert M, Cronquist S, Elner A, Eneroth CM, Hedner P, Lindvall-Axelsson M, Nordstrom CH & Stromblad LG 1991 Early postoperative basal GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report of 39 patients. Journal of Internal Medicine 230 49-54.
46. Van Lindert E, Hey O, Boecher-Schwarz H & Perceczky A 1997 Treatment results of acromegaly as analyzed by different criteria. Acta Neurochirurgica 139 905-913.
47. Webb SM, Rigla M, Wagner A, Oliver B & Bartumeus F 1999 Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 84 3696-3700.
48. Wilson CB 1984 A decade of pituitary microsurgery: the Herbert Olivecrona Lecture. Journal of Neurosurgery 61 814-833.